Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-05

Clinical Trial Update: Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23 [NA]

View source ↗

Summary

A completed clinical trial investigating a dietary additive phosphorus effect on proteinuria and FGF-23; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Geisinger Clinic | Conditions: Albuminuria | NA | Status: COMPLETED | Results posted: 2019-06-05